Combinations of LABA + LAMA + ICS in separate inhalers are used in patients with asthma and COPD to improve and control symptoms and to reduce exacerbations. The 4-year UPLIFT study provides the ...

Inhalers for COPD provide steroids, bronchodilators, or combination drugs. The three types differ in the mechanism by which the medication is inhaled and have different instructions for use.

Available treatments for COPD are ... the disease 7. Inhaled corticosteroids (ICS), short- and long-acting β 2-agonists (SABA and LABA), long-acting muscarinic antagonists (LAMA) and fixed ...

Further, if initial pharmacotherapy with LABA or LAMA after a COPD exacerbation does not elicit an appropriate patient response and if guideline concordance, inhaler technique, and comorbidities ...

whereas group B must be given long-acting muscarinic antagonist (LAMA) or a LABA, and groups C and D should take an ICS in combination. In terms of stable COPD management, the most important ...